Brief: Irlab’S Drug Candidate Pirepemat’S Phase I Data Published In Scientific Journal Cpdd

IRLAB Therapeutics AB

15/06/2021 09:03

June 15 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB’S DRUG CANDIDATE PIREPEMAT’S PHASE I DATA PUBLISHED IN SCIENTIFIC JOURNAL CPDD
    * PIREPEMAT WAS SAFE AND WELL-TOLERATED IN HEALTHY MALE VOLUNTEERS.

Source text for Eikon:  ID:nMFN5ZcHwN 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))